iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis.
Eur J Pharmacol
; 850: 167-179, 2019 May 05.
Article
in En
| MEDLINE
| ID: mdl-30771347
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Berberine
/
Colitis, Ulcerative
/
Proteomics
/
Molecular Targeted Therapy
Limits:
Animals
Language:
En
Journal:
Eur J Pharmacol
Year:
2019
Document type:
Article
Country of publication: